@entity1224 ( @entity1224 ) is a rare but life-threatening complication of oral anticoagulants requiring early recognition. However, no consensus exists regarding the best approach to treatment. We therefore, sought to systematically review the published literature on @entity1224 to elaborate its demographic and clinical characteristics, treatment, complications, and outcomes. A systematic electronic search of PubMed and EMBASE for case reports, case series, and related articles of @entity1224 related to @entity1229 published from inception (November 1950) to March 2015 was carried out. Categorical variables were expressed as percentage and continuous variables as mean    standard deviation (SD). Statistical analysis was done using Statistical Package for the Social Sciences (SPSS) version 20.0. All cases were reported to have @entity1224 as a complication of anticoagulation therapy with @entity1229 . Demographic and clinical characteristics, treatment, complications and outcomes of @entity1224 were studied. Thirty-eight cases of @entity1224 were identified from 34 reports in the literature. No gender preponderance (male = 52.78%) was seen and the average age of presentation was 60.11    12.50 years. @entity1282 , sore throat, and neck swelling were the most common symptoms and the mean international normalized ratio (INR)at presentation was 8.07    4.04. Most cases had sublingual @entity1410 (66.57%) followed by @entity1410 (27.03%). Of the cases, 48.65% were managed conservatively while the rest underwent either cricothyrotomy or intubation with the time to resolution being 7.69    5.44 days. @entity1224 is a rare butpotentially serious complication of @entity1229 therapy. It is more common in the elderly population with supratherapeutic INR; inciting events were present in many cases. Overall, it has a good prognosis with significant morbidity present only if concomitant respiratory compromise is present. Reversal of anticoagulation with low threshold for artificial airway placement in the event of airway compromise leads to a favorable outcome in most cases.

Upper Airway @entity1410 Secondary to XXXX Therapy: A Systematic Review of Reported Cases.

@entity1229 :: ('MESH:D014859', 'Chemical') :: ['warfarin'] @entity1410 :: ('MESH:D006406', 'Disease') :: ['retropharyngeal hematoma', 'hematoma'] @entity1282 :: ('MESH:D003680', 'Disease') :: ['Dysphagia'] @entity1224 :: ('MESH:D000402', 'Disease') :: ['UAH', 'Upper airway hematoma']
@entity1229 :: (MESH:D014859,Chemical) :: ['Warfarin']
